Cargando…

An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1‐positive neuroendocrine carcinoma

Neuroendocrine carcinoma (NEC) is a highly aggressive subtype of the neuroendocrine tumor with an extremely poor prognosis. We have previously conducted a comprehensive genomic analysis of over 100 cases of NEC of the gastrointestinal system (GIS‐NEC) and unraveled its unique and organ‐specific geno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horie, Masafumi, Tanaka, Hidenori, Suzuki, Masami, Sato, Yoshihiko, Takata, So, Takai, Erina, Miyashita, Naoya, Saito, Akira, Nakatani, Yoichiro, Yachida, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236617/ https://www.ncbi.nlm.nih.gov/pubmed/36840413 http://dx.doi.org/10.1111/cas.15764

Ejemplares similares

Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
por: Ohmoto, Akihiro, et al.
Publicado: (2018)

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
por: Ohmoto, Akihiro, et al.
Publicado: (2019)

ASCL1 regulates super‐enhancer‐associated miRNAs to define molecular subtypes of small cell lung cancer
por: Miyakawa, Kazuko, et al.
Publicado: (2022)

Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
por: Takai, Erina, et al.
Publicado: (2016)

Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV‐related oropharyngeal cancer and cancer of unknown primary
por: Tanaka, Hidenori, et al.
Publicado: (2021)

Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
por: Yachida, Shinichi, et al.
Publicado: (2022)

EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression
por: Bhinge, Kaustubh, et al.
Publicado: (2017)

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future
por: Ohmoto, Akihiro, et al.
Publicado: (2017)

The N terminus of Ascl1 underlies differing proneural activity of mouse and Xenopus Ascl1 proteins
por: Hardwick, Laura J.A., et al.
Publicado: (2018)

Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine Neoplasias
por: Sharma, Rohini, et al.
Publicado: (2021)

ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1
por: Liu, D, et al.
Publicado: (2018)

Clonal dynamics of circulating tumor DNA during immune checkpoint blockade therapy for melanoma
por: Takai, Erina, et al.
Publicado: (2021)

ELFE at CERN
por: Burkhardt, H
Publicado: (1999)

Germline mutations in Japanese familial pancreatic cancer patients
por: Takai, Erina, et al.
Publicado: (2016)

The Epithelial Sodium Channel (αENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors
por: He, Min, et al.
Publicado: (2018)

Reorganization of the host epigenome by a viral oncogene
por: Ferrari, Roberto, et al.
Publicado: (2012)

Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma
por: Enfield, Katey S. S., et al.
Publicado: (2019)

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
por: Meder, Lydia, et al.
Publicado: (2015)

ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation
por: Alam, Sk. Kayum, et al.
Publicado: (2020)

The ELFE programme and project
por: Laget, J M
Publicado: (1997)

The Nursery Elf (Poetry)
Publicado: (1881)

Subcellular localisation modulates ubiquitylation and degradation of Ascl1
por: Gillotin, Sébastien, et al.
Publicado: (2018)

Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome
por: Jacob, John, et al.
Publicado: (2014)

ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
por: Luk, Ian Y., et al.
Publicado: (2018)

Occupational Carcinogens: ELF MFs
por: Mild, Kjell Hanson, et al.
Publicado: (2005)

ELFE: an electron laboratory for Europe
por: Laget, J M
Publicado: (1995)

From ELF to Compressibility in Solids
por: Contreras-García, Julia, et al.
Publicado: (2015)

THE NATIONAL ELF SERVICE …… NOT THE NHS
por: Spence, Roy
Publicado: (2016)

Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic cancer patients
por: Tanaka, Junko, et al.
Publicado: (2023)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
por: Liu, Feng, et al.
Publicado: (2017)

Transcriptional control of vertebrate neurogenesis by the proneural factor Ascl1
por: Vasconcelos, Francisca F., et al.
Publicado: (2014)

Oligodendrocyte development in the embryonic tuberal hypothalamus and the influence of Ascl1
por: Marsters, Candace M., et al.
Publicado: (2016)

The Potential of Targeting Brain Pathology with Ascl1/Mash1
por: Tang, Bor Luen
Publicado: (2017)

Common ELF1 deletion in prostate cancer bolsters oncogenic ETS function, inhibits senescence and promotes docetaxel resistance
por: Budka, Justin A., et al.
Publicado: (2018)

Transcript Profiling of Elf5(+/−) Mammary Glands during Pregnancy Identifies Novel Targets of Elf5
por: Rogers, Renee L., et al.
Publicado: (2010)

The ELF4-ELF3-LUX Complex Links the Circadian Clock to Diurnal Control of Hypocotyl Growth
por: Nusinow, Dmitri A., et al.
Publicado: (2011)

Targeting oncogenic TERT promoter variants by allele-specific epigenome editing
por: Kouroukli, Alexandra G., et al.
Publicado: (2023)

ELFE: New machine proposed for Europe
Publicado: (1995)

A New View of ELF-EMFs
por: Tenenbaum, DJ
Publicado: (2000)

The ELFE project: an electron accelerator for Europe
por: Pirner, H J
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_7a443o3q5tal1gol43cgb3nrpp